221 related articles for article (PubMed ID: 36129032)
1. Intravenous Thrombolysis With Alteplase at 0.6 mg/kg in Patients With Ischemic Stroke Taking Direct Oral Anticoagulants.
Okada T; Yoshimoto T; Wada S; Yoshimura S; Chiba T; Egashira S; Kimura S; Shiozawa M; Inoue M; Ihara M; Toyoda K; Takashima H; Koga M
J Am Heart Assoc; 2022 Oct; 11(19):e025809. PubMed ID: 36129032
[TBL] [Abstract][Full Text] [Related]
2. Association of Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants With Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase.
Kam W; Holmes DN; Hernandez AF; Saver JL; Fonarow GC; Smith EE; Bhatt DL; Schwamm LH; Reeves MJ; Matsouaka RA; Khan YM; Unverdorben M; Birmingham MC; Lyden PD; Asimos AW; Altschul D; Schoonover TL; Jumaa MA; Nomura JT; Suri MFK; Moore SA; Lafranchise EF; Olson D; Peterson ED; Xian Y
JAMA; 2022 Feb; 327(8):760-771. PubMed ID: 35143601
[TBL] [Abstract][Full Text] [Related]
3. Intravenous tPA (Tissue-Type Plasminogen Activator) in Patients With Acute Ischemic Stroke Taking Non-Vitamin K Antagonist Oral Anticoagulants Preceding Stroke.
Jin C; Huang RJ; Peterson ED; Laskowitz DT; Hernandez AF; Federspiel JJ; Schwamm LH; Bhatt DL; Smith EE; Fonarow GC; Xian Y
Stroke; 2018 Sep; 49(9):2237-2240. PubMed ID: 30354981
[TBL] [Abstract][Full Text] [Related]
4. Use of Intravenous Recombinant Tissue Plasminogen Activator in Patients With Acute Ischemic Stroke Who Take Non-Vitamin K Antagonist Oral Anticoagulants Before Stroke.
Xian Y; Federspiel JJ; Hernandez AF; Laskowitz DT; Schwamm LH; Bhatt DL; Smith EE; Fonarow GC; Peterson ED
Circulation; 2017 Mar; 135(11):1024-1035. PubMed ID: 28119380
[TBL] [Abstract][Full Text] [Related]
5. Routine Use of Tenecteplase for Thrombolysis in Acute Ischemic Stroke.
Zhong CS; Beharry J; Salazar D; Smith K; Withington S; Campbell BCV; Wilson D; Le Heron C; Mason D; Duncan R; Reimers J; Mein-Smith F; Diprose WK; Barber PA; Ranta A; Fink JN; Wu TY
Stroke; 2021 Mar; 52(3):1087-1090. PubMed ID: 33588597
[TBL] [Abstract][Full Text] [Related]
6. Support for Thrombolytic Therapy for Acute Stroke Patients on Direct Oral Anticoagulants: Mortality and Bleeding Complications.
Koscumb P; Murphy L; Talbott M; Nuti S; Golovko G; Shaltoni H; Jehle D
West J Emerg Med; 2024 May; 25(3):399-406. PubMed ID: 38801047
[TBL] [Abstract][Full Text] [Related]
7. Effect of Time to Thrombolysis on Clinical Outcomes in Patients With Acute Ischemic Stroke Treated With Tenecteplase Compared to Alteplase: Analysis From the AcT Randomized Controlled Trial.
Singh N; Almekhlafi MA; Bala F; Ademola A; Coutts SB; Deschaintre Y; Khosravani H; Buck B; Appireddy R; Moreau F; Gubitz G; Tkach A; Catanese L; Dowlatshahi D; Medvedev G; Mandzia J; Pikula A; Shankar JJ; Ghrooda E; Poppe AY; Williams H; Field TS; Manosalva A; Siddiqui MM; Zafar A; Imoukhoude O; Hunter G; Shamy M; Demchuk AM; Claggett BL; Hill MD; Sajobi TT; Swartz RH; Menon BK
Stroke; 2023 Nov; 54(11):2766-2775. PubMed ID: 37800372
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Reteplase Versus Alteplase for Acute Ischemic Stroke: A Phase 2 Randomized Controlled Trial.
Li S; Wang X; Jin A; Liu G; Gu H; Li H; Campbell BCV; Fisher M; Yang Y; Wei Y; Wang J; Wang Y; Zhao X; Liu L; Li Z; Meng X; Wang Y
Stroke; 2024 Feb; 55(2):366-375. PubMed ID: 38152962
[TBL] [Abstract][Full Text] [Related]
9. Revascularization outcomes following acute ischemic stroke in patients taking direct oral anticoagulants: a single hospital cohort study.
Frol S; Šabovič M; Popovič KŠ; Oblak JP
J Thromb Thrombolysis; 2021 Jan; 51(1):194-202. PubMed ID: 32506363
[TBL] [Abstract][Full Text] [Related]
10. Thrombolysis for Wake-Up Stroke Versus Non-Wake-Up Unwitnessed Stroke: EOS Individual Patient Data Meta-Analysis.
Kamogawa N; Miwa K; Toyoda K; Jensen M; Inoue M; Yoshimura S; Fukuda-Doi M; Kitazono T; Boutitie F; Ma H; Ringleb P; Wu O; Schwamm LH; Warach S; Hacke W; Davis SM; Donnan GA; Gerloff C; Thomalla G; Koga M;
Stroke; 2024 Apr; 55(4):895-904. PubMed ID: 38456303
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of intravenous thrombolysis in patients with acute ischemic stroke taking direct oral anticoagulants prior to stroke: a meta-analysis.
Liang H; Wang X; Quan X; Qin B; Zhang J; Liang S; Liang Z
J Neurol; 2023 Sep; 270(9):4192-4200. PubMed ID: 37314507
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of outcomes following intravenous thrombolysis in patients with ischemic stroke on direct oral anticoagulants.
Behnoush AH; Khalaji A; Bahiraie P; Gupta R
BMC Neurol; 2023 Dec; 23(1):440. PubMed ID: 38102548
[TBL] [Abstract][Full Text] [Related]
13. Safety of recanalization therapy in patients with acute ischemic stroke on direct oral anticoagulants: A sub-analysis of PASTA registry study.
Suda S; Abe A; Iguchi Y; Yagita Y; Kanzawa T; Okubo S; Fujimoto S; Kono Y; Kimura K;
J Neurol Sci; 2023 May; 448():120639. PubMed ID: 37030185
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Different Dosages of Alteplase in Atrial Fibrillation-Related Acute Ischemic Stroke After Intravenous Thrombolysis: A Nationwide, Multicenter, Prospective Cohort Study in Taiwan.
Lin SF; Chen CF; Hu HH; Ho BL; Chen CH; Chan L; Lin HJ; Sun Y; Lin YY; Chen PL; Lin SK; Wei CY; Lin YT; Lee JT; Chao AC;
J Am Heart Assoc; 2022 Feb; 11(3):e023032. PubMed ID: 35048714
[TBL] [Abstract][Full Text] [Related]
15. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.
Hacke W; Kaste M; Bluhmki E; Brozman M; Dávalos A; Guidetti D; Larrue V; Lees KR; Medeghri Z; Machnig T; Schneider D; von Kummer R; Wahlgren N; Toni D;
N Engl J Med; 2008 Sep; 359(13):1317-29. PubMed ID: 18815396
[TBL] [Abstract][Full Text] [Related]
16. Idarucizumab Reversal of Dabigatran in Patients with Acute Ischemic Stroke and Intracranial Hemorrhage: Comparison with Non-idarucizumab-Treated Patients.
Frol S; Sernec LP; Hudnik LK; Šabovič M; Oblak JP
CNS Drugs; 2021 Feb; 35(2):233-242. PubMed ID: 33548038
[TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of Dual Thrombolytic Therapy With Mutant Prourokinase and Small Bolus Alteplase for Ischemic Stroke: A Randomized Clinical Trial.
van der Ende NAM; Roozenbeek B; Smagge LEM; Luijten SPR; Aerden LAM; Kraayeveld P; van den Wijngaard IR; Lycklama À Nijeholt GJ; den Hertog HM; Flach HZ; Postma AA; Roosendaal SD; Krietemeijer GM; Yo LSF; de Maat MPM; Nieboer D; Del Zoppo GJ; Meurer WJ; Lingsma HF; van der Lugt A; Dippel DWJ;
JAMA Neurol; 2023 Jul; 80(7):714-722. PubMed ID: 37213122
[TBL] [Abstract][Full Text] [Related]
18. Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience.
Šaňák D; Jakubíček S; Černík D; Herzig R; Kunáš Z; Mikulík R; Ostrý S; Reif M; Rohan V; Tomek A; Veverka T
J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2479-2483. PubMed ID: 29807757
[TBL] [Abstract][Full Text] [Related]
19. Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis.
Shahjouei S; Tsivgoulis G; Goyal N; Sadighi A; Mowla A; Wang M; Seiffge DJ; Zand R
Stroke; 2020 Feb; 51(2):533-541. PubMed ID: 31884908
[TBL] [Abstract][Full Text] [Related]
20. Safety outcomes of early initiation of antithrombotic agents within 24 h after intravenous alteplase at 0.6 mg/kg.
Chiba T; Yoshimoto T; Wada S; Shiozawa M; Yoshimura S; Kimura S; Inoue M; Toyoda K; Ihara M; Koga M
J Neurol Sci; 2023 Feb; 445():120546. PubMed ID: 36657370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
